Yumi Itoh

1.1k total citations
30 papers, 592 citations indexed

About

Yumi Itoh is a scholar working on Molecular Biology, Infectious Diseases and Nutrition and Dietetics. According to data from OpenAlex, Yumi Itoh has authored 30 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Infectious Diseases and 5 papers in Nutrition and Dietetics. Recurrent topics in Yumi Itoh's work include SARS-CoV-2 and COVID-19 Research (6 papers), melanin and skin pigmentation (4 papers) and COVID-19 Clinical Research Studies (3 papers). Yumi Itoh is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (6 papers), melanin and skin pigmentation (4 papers) and COVID-19 Clinical Research Studies (3 papers). Yumi Itoh collaborates with scholars based in Japan, United States and France. Yumi Itoh's co-authors include Hiroshi Takemori, A Kumagai, Toru Okamoto, Hiroyuki Fuchino, Tatsuya Suzuki, Nobuo Kawahara, Yusuke Sakai, Yasuo Nagaoka, Hidehisa Kawahara and Daisuke Motooka and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Yumi Itoh

28 papers receiving 586 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yumi Itoh Japan 14 265 155 79 70 67 30 592
Julie A. Webster Australia 14 261 1.0× 68 0.4× 142 1.8× 190 2.7× 42 0.6× 23 729
Da‐Wei Yeh Taiwan 14 365 1.4× 82 0.5× 247 3.1× 76 1.1× 54 0.8× 23 816
Laura Collins United States 13 196 0.7× 51 0.3× 133 1.7× 60 0.9× 71 1.1× 30 618
Keun Jae Ahn South Korea 12 225 0.8× 34 0.2× 45 0.6× 44 0.6× 45 0.7× 29 587
Camille Garcia France 11 302 1.1× 45 0.3× 33 0.4× 39 0.6× 67 1.0× 20 476
Carole Berruyer-Pouyet France 9 361 1.4× 52 0.3× 287 3.6× 117 1.7× 71 1.1× 10 832
Dingyuan Ma China 14 504 1.9× 40 0.3× 84 1.1× 82 1.2× 21 0.3× 55 775
Jia‐Jun Liao United States 9 447 1.7× 120 0.8× 304 3.8× 59 0.8× 52 0.8× 15 710
Tomokazu S. Sumida United States 18 456 1.7× 65 0.4× 312 3.9× 43 0.6× 30 0.4× 34 1.0k
Jesús Gardeazábal Spain 18 199 0.8× 35 0.2× 194 2.5× 100 1.4× 124 1.9× 60 845

Countries citing papers authored by Yumi Itoh

Since Specialization
Citations

This map shows the geographic impact of Yumi Itoh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yumi Itoh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yumi Itoh more than expected).

Fields of papers citing papers by Yumi Itoh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yumi Itoh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yumi Itoh. The network helps show where Yumi Itoh may publish in the future.

Co-authorship network of co-authors of Yumi Itoh

This figure shows the co-authorship network connecting the top 25 collaborators of Yumi Itoh. A scholar is included among the top collaborators of Yumi Itoh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yumi Itoh. Yumi Itoh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ito, Takaaki, Yusuke Sakai, Keisuke Nishioka, et al.. (2025). Engineered ACE2 decoy in dry powder form for inhalation: A novel therapy for SARS-CoV-2 variants. Molecular Therapy — Methods & Clinical Development. 33(2). 101459–101459. 1 indexed citations
2.
Itoh, Yumi, Yoichi Miyamoto, Makoto Tokunaga, et al.. (2024). Importin-7-dependent nuclear translocation of the Flavivirus core protein is required for infectious virus production. PLoS Pathogens. 20(8). e1012409–e1012409. 2 indexed citations
3.
Higuchi, Yusuke, Yumi Itoh, Tatsuya Suzuki, et al.. (2023). A computationally designed ACE2 decoy has broad efficacy against SARS-CoV-2 omicron variants and related viruses in vitro and in vivo. Communications Biology. 6(1). 513–513. 11 indexed citations
4.
5.
Katahira, Jun, Mayo Yasugi, Ryosuke Sasaki, et al.. (2023). Nsp14 of SARS-CoV-2 inhibits mRNA processing and nuclear export by targeting the nuclear cap-binding complex. Nucleic Acids Research. 51(14). 7602–7618. 11 indexed citations
6.
Inoue, Takeshi, Ryo Shinnakasu, Hiromi Yamamoto, et al.. (2022). Antibody feedback contributes to facilitating the development of Omicron-reactive memory B cells in SARS-CoV-2 mRNA vaccinees. The Journal of Experimental Medicine. 220(2). 18 indexed citations
7.
Hashimoto, Rina, Yumi Itoh, Ayaka Sakamoto, et al.. (2022). Cell response analysis in SARS-CoV-2 infected bronchial organoids. Communications Biology. 5(1). 516–516. 35 indexed citations
8.
Inaba, Tohru, Takao Arimori, Daisuke Motooka, et al.. (2022). An engineered ACE2 decoy neutralizes the SARS-CoV-2 Omicron variant and confers protection against infection in vivo. Science Translational Medicine. 14(650). eabn7737–eabn7737. 34 indexed citations
9.
Miyamoto, Yoichi, Yumi Itoh, Tatsuya Suzuki, et al.. (2022). SARS-CoV-2 ORF6 disrupts nucleocytoplasmic trafficking to advance viral replication. Communications Biology. 5(1). 483–483. 39 indexed citations
10.
Higuchi, Yusuke, Tatsuya Suzuki, Takao Arimori, et al.. (2021). Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2. Nature Communications. 12(1). 3802–3802. 76 indexed citations
11.
Yahara, Yasuhito, Hiroshi Takemori, Minoru Okada, et al.. (2016). Pterosin B prevents chondrocyte hypertrophy and osteoarthritis in mice by inhibiting Sik3. Nature Communications. 7(1). 10959–10959. 72 indexed citations
12.
Itoh, Yumi, Hiroyuki Fuchino, Yasuhito Yahara, et al.. (2015). Salt-inducible Kinase 3 Signaling Is Important for the Gluconeogenic Programs in Mouse Hepatocytes. Journal of Biological Chemistry. 290(29). 17879–17893. 42 indexed citations
13.
Kumagai, A, Hiroyuki Fuchino, Yumi Itoh, et al.. (2015). Callicarpa longissima extract, carnosol-rich, potently inhibits melanogenesis in B16F10 melanoma cells. Journal of Natural Medicines. 70(1). 28–35. 15 indexed citations
14.
Chen, Chun‐Yen, Masanori Asakura, Hiroshi Asanuma, et al.. (2012). Plasma adiponectin levels predict cardiovascular events in the observational Arita Cohort Study in Japan: the importance of the plasma adiponectin levels. Hypertension Research. 35(8). 843–848. 21 indexed citations
15.
Kumagai, A, Nanao Horike, Tatsuya Uebi, et al.. (2011). A Potent Inhibitor of SIK2, 3, 3′, 7-Trihydroxy-4′-Methoxyflavon (4′-O-Methylfisetin), Promotes Melanogenesis in B16F10 Melanoma Cells. PLoS ONE. 6(10). e26148–e26148. 33 indexed citations
16.
Horike, Nanao, A Kumagai, Yumi Itoh, et al.. (2010). Downregulation of SIK2 expression promotes the melanogenic program in mice. Pigment Cell & Melanoma Research. 23(6). 809–819. 58 indexed citations
17.
Fujiki, Kazuhiko, Yumi Itoh, Shinji Suzuki, et al.. (2003). A case of spontaneous submucosal hematoma. Progress of Digestive Endoscopy. 63(2). 76–77. 1 indexed citations
18.
Yamada, Takahiro, et al.. (1998). Localization of vascular endothelial growth factor in synovial membrane mast cells: examination with ”multi-labelling subtraction immunostaining". Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 433(6). 567–570. 23 indexed citations
19.
Itoh, Yumi, et al.. (1995). Zinc distribution in malignant tumors. 6(1). 45–50. 3 indexed citations
20.
ITOYAMA, Youichi, A Fukumura, Yumi Itoh, Eiichirou Urasaki, & Kaori Koga. (1987). [Primary brain tumor complicating subdural hematoma].. PubMed. 39(12). 1157–61. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julie A. Webster Breakdown of academic impact, for papers by Da‐Wei Yeh Breakdown of academic impact, for papers by Laura Collins Breakdown of academic impact, for papers by Keun Jae Ahn Breakdown of academic impact, for papers by Camille Garcia Breakdown of academic impact, for papers by Carole Berruyer-Pouyet Breakdown of academic impact, for papers by Dingyuan Ma Breakdown of academic impact, for papers by Jia‐Jun Liao Breakdown of academic impact, for papers by Tomokazu S. Sumida Breakdown of academic impact, for papers by Jesús Gardeazábal
Rankless by CCL
2026